CTNNBIP1 and ovarian carcinoma: Another genetic variant, CTNNBIP1 rs935072, is implicated in chemoresistance by altering the binding strength of miR-27a-3p to the CTNNBIP1 3′UTR, consequently affecting CTNNBIP1 mRNA expression levels in epithelial ovarian cancer patients [36].